Found 18 matching trials
CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia
PHASE2The goal of this clinical trial is to learn whether CM336, a BCMA/CD3 bispe...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
CM336 for Active Sjogren's Syndrome Study
PHASE1The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Location
Peking Union Medical College Hospital
Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients
PHASE3The purpose of this study is to compare the efficacy between CM336 and inve...
Location
Institute of Hematology & Blood Diseases Hospital
CM336-SOC for Dynamically High-Risk Multiple Myeloma Study
PHASE2This is a single-arm, open-label study to evaluate the efficacy and safety ...
Location
Multiple Locations
CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Renal Impairment
PHASE2This study is a single-center, single-arm, open-label, Phase II interventio...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
BCMA/CD3 BsAb Therapy for POEMS Syndrome
PHASE2This is a prospective, single-arm, investigator-initiated clinical trial ev...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Radiation Combined With BCMA/CD3 Bispecific Antibody Therapy for Solitary Bone Plasmacytoma With Mild Bone Marrow Infiltration
PHASE2This is a prospective, single-arm, single-center clinical trial designed to...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis
PHASE2This is a prospective, single-arm, single-center clinical study designed to...
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia
PHASE2To evaluate the efficacy and safety of CM336 in the treatment of refractory...
Location
Chinese Academy of Medical Science and Blood Disease Hospital
A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1This is a multi-center, open-label, Phase 1/2 study in China to evaluate th...
Location
Peking University Third Hospital